Citations (56)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (11)
Farid Mostafaei, Somayeh Mahdinloo, Hadi Valizadeh, Salar Hemmati, Mahdieh Abdi, Muhammad Sarfraz, Behzad Baradaran & Parvin Zakeri-Milani. (2023) An Update Review of Smart Nanotherapeutics and Liver Cancer: Opportunities and Challenges. Nanomedicine 18:25, pages 1855-1873.
Read now
Read now
Maryamsadat Shahidi, Omid Abazari, Parisa Dayati, Javad Zavar Reza, Mohammad Hossein Modarressi, Davood Tofighi, Bibi Fatemeh Haghiralsadat & Fatemeh Oroojalian. (2023) Using Chitosan-Stabilized, Hyaluronic Acid-Modified Selenium Nanoparticles to Deliver CD44-Targeted PLK1 siRNAs for Treating Bladder Cancer. Nanomedicine 18:3, pages 259-277.
Read now
Read now
Xiao Zhang, Yue Chen, Dongli Sun, Xiaojun Zhu, Xia Ying, Yao Yao, Weidong Fei & Caihong Zheng. (2022) Emerging pharmacologic interventions for pre-eclampsia treatment. Expert Opinion on Therapeutic Targets 26:8, pages 739-759.
Read now
Read now
Gizem Tezel, Selin Seda Timur, Filiz Kuralay, R. Neslihan Gürsoy, Kezban Ulubayram, Levent Öner & Hakan Eroğlu. (2021) Current status of micro/nanomotors in drug delivery. Journal of Drug Targeting 29:1, pages 29-45.
Read now
Read now
Changbing Wang, Yu Xia, Shaochuan Huo, Diwen Shou, Qing Mei, Wenjuan Tang, Yinghua Li, Hongsheng Liu, Yongjian Zhou & Bing Zhu. (2020) Silencing of MEF2D by siRNA Loaded Selenium Nanoparticles for Ovarian Cancer Therapy. International Journal of Nanomedicine 15, pages 9759-9770.
Read now
Read now
Zuxian Chen, Shangcong Han, Xiaotang Yang, Lisa Xu, Hong Qi, Guizhou Hao, Jie Cao, Yan Liang, Qingming Ma, Guimin Zhang & Yong Sun. (2020) Overcoming Multiple Absorption Barrier for Insulin Oral Delivery Using Multifunctional Nanoparticles Based on Chitosan Derivatives and Hyaluronic Acid. International Journal of Nanomedicine 15, pages 4877-4898.
Read now
Read now
Jiayu Zhong, Yu Xia, Liang Hua, Xiaomin Liu, Misi Xiao, Tiantian Xu, Bing Zhu & Hong Cao. (2019) Functionalized selenium nanoparticles enhance the anti-EV71 activity of oseltamivir in human astrocytoma cell model. Artificial Cells, Nanomedicine, and Biotechnology 47:1, pages 3485-3491.
Read now
Read now
Jianjun Zou, Shan Su, Zhuohong Chen, Feng Liang, Yunyun Zeng, Wenchang Cen, Xianlan Zhang, Yu Xia & Donglan Huang. (2019) Hyaluronic acid-modified selenium nanoparticles for enhancing the therapeutic efficacy of paclitaxel in lung cancer therapy. Artificial Cells, Nanomedicine, and Biotechnology 47:1, pages 3456-3464.
Read now
Read now
Yu Sakurai & Hideyoshi Harashima. (2019) Hyaluronan-modified nanoparticles for tumor-targeting. Expert Opinion on Drug Delivery 16:9, pages 915-936.
Read now
Read now
Yu Xia, Jiayu Zhong, Mingqi Zhao, Ying Tang, Ning Han, Liang Hua, Tiantian Xu, Changbing Wang & Bing Zhu. (2019) Galactose-modified selenium nanoparticles for targeted delivery of doxorubicin to hepatocellular carcinoma. Drug Delivery 26:1, pages 1-11.
Read now
Read now
Yu Xia, Yi Chen, Liang Hua, Mingqi Zhao, Tiantian Xu, Changbing Wang, Yinghua Li & Bing Zhu. (2018) Functionalized selenium nanoparticles for targeted delivery of doxorubicin to improve non-small-cell lung cancer therapy. International Journal of Nanomedicine 13, pages 6929-6939.
Read now
Read now
Articles from other publishers (45)
Seyedeh Setareh Samaei, Mahshid Daryab, Sarah Gholami, Aryan Rezaee, Navid Fatehi, Romina Roshannia, Saeed Hashemi, Nazanin Javani, Parham Rahmanian, Reza Amani-Beni, Mohammad Arad Zandieh, Noushin Nabavi, Mohsen Rashidi, Neda Malgard, Mehrdad Hashemi & Afshin Taheriazam. (2024) Multifunctional and stimuli-responsive liposomes in hepatocellular carcinoma diagnosis and therapy. Translational Oncology 45, pages 101975.
Crossref
Crossref
Elena G. Varlamova. (2024) Molecular Mechanisms of the Therapeutic Effect of Selenium Nanoparticles in Hepatocellular Carcinoma. Cells 13:13, pages 1102.
Crossref
Crossref
Rohitas Deshmukh, Rajesh Singh, Sandeep Sharma, Ashwini Kumar Mishra & Ranjit Kumar Harwansh. (2024) A Snapshot of Selenium-enclosed Nanoparticles for the Management of Cancer. Current Pharmaceutical Design 30:11, pages 841-858.
Crossref
Crossref
Feng Chen, Wang Zhang, Xinran Gao, Hui Yuan & Kehai Liu. (2023) The Role of Small Interfering RNAs in Hepatocellular Carcinoma. Journal of Gastrointestinal Cancer 55:1, pages 26-40.
Crossref
Crossref
Xintong Zhang, Yanhong Liu, Wei Liu, Liqing Chen, Mingji Jin, Zhonggao Gao & Wei Huang. (2024) Macrophage-hitchhiking interleukin-10 plasmid DNA delivery system modulates rheumatoid arthritis microenvironment via the re-polarization of macrophages. Nano Today 54, pages 102068.
Crossref
Crossref
Hongli Huang, Hanqing Chen, Diwen Shou, Ying Quan, Jiemin Cheng, Huiting Chen, Gang Ning, Yongqiang Li, Yu Xia & Yongjian Zhou. (2023) Engineering siRNA-loaded and RGDfC-targeted selenium nanoparticles for highly efficient silencing of DCBLD2 gene for colorectal cancer treatment. Discover Nano 18:1.
Crossref
Crossref
Michael V. Goltyaev & Elena G. Varlamova. (2023) The Role of Selenium Nanoparticles in the Treatment of Liver Pathologies of Various Natures. International Journal of Molecular Sciences 24:13, pages 10547.
Crossref
Crossref
Sisi Yang, Chengwei Cai, Huanqiu Wang, Xueqing Ma, Anwen Shao, Jifang Sheng & Chengbo Yu. (2022) Drug delivery strategy in hepatocellular carcinoma therapy. Cell Communication and Signaling 20:1.
Crossref
Crossref
Maria John Newton Amaldoss, Jia-Lin Yang, Pramod Koshy, Ashwin Unnikrishnan & Charles C. Sorrell. (2022) Inorganic nanoparticle-based advanced cancer therapies: Promising combination strategies. Drug Discovery Today 27:12, pages 103386.
Crossref
Crossref
Ashish Ranjan Sharma, Yeon-Hee Lee, Altanzul Bat-Ulzii, Manojit Bhattacharya, Chiranjib Chakraborty & Sang-Soo Lee. (2022) Recent advances of metal-based nanoparticles in nucleic acid delivery for therapeutic applications. Journal of Nanobiotechnology 20:1.
Crossref
Crossref
Min Guo, Ying Tang, Liang Hua, Wanling Li, Guifang Gong, Yali Zhu, Bing Zhu & Yu Xia. (2022) Functionalized Selenium Nanoparticles Enhance Anticancer Efficacy of Doxorubicin for Hepatocellular Carcinoma Therapy. Advances in Materials Science and Engineering 2022, pages 1-9.
Crossref
Crossref
Qing Mei, Diwen Shou, Ying Quan, Jiemin Cheng, Pan Pan, Huiting Chen, Hongli Huang, Yongqiang Li, Yu Xia & Yongjian Zhou. (2022) Inhibiting M1 Macrophage Polarization, Using Small Interfering Forkhead Box Class Family Protein 1 (FOXO1)-Loaded Selenium Nanoparticles, Alleviates Hepatic Steatosis. Science of Advanced Materials 14:7, pages 1175-1184.
Crossref
Crossref
Haishan Wu, Ting Guo, Jian Nan, Liu Yang, Guangfu Liao, Hyun Jin Park & Jinglei Li. (2022) Hyaluronic‐Acid‐Coated Chitosan Nanoparticles for Insulin Oral Delivery: Fabrication, Characterization, and Hypoglycemic Ability. Macromolecular Bioscience 22:7.
Crossref
Crossref
Raquibun Nisha, Pranesh Kumar, Umesh Kumar, Nidhi Mishra, Priyanka Maurya, Priya Singh, Heena Tabassum, Alka, Samipta Singh, Anupam Guleria & Shubhini A. Saraf. (2022) Assessment of hyaluronic acid-modified imatinib mesylate cubosomes through CD44 targeted drug delivery in NDEA-induced hepatic carcinoma. International Journal of Pharmaceutics 622, pages 121848.
Crossref
Crossref
Florin Graur, Aida Puia, Emil Ioan Mois, Septimiu Moldovan, Alexandra Pusta, Cecilia Cristea, Simona Cavalu, Cosmin Puia & Nadim Al Hajjar. (2022) Nanotechnology in the Diagnostic and Therapy of Hepatocellular Carcinoma. Materials 15:11, pages 3893.
Crossref
Crossref
Goknur Kara, George A. Calin & Bulent Ozpolat. (2022) RNAi-based therapeutics and tumor targeted delivery in cancer. Advanced Drug Delivery Reviews 182, pages 114113.
Crossref
Crossref
Lifen Yang, Xiaobo Zhou, Maozhang Li, Jinxian Liao, Jianrui Fan, Shumin Fang, Weide Zhong & Jiahong Chen. (2021)
Arginine-Glycine-Aspartic-Modified Silver Nanoparticles Improve the
In Vitro
Anti-Cancer Efficacy of Adriamycin for Prostate Cancer Treatment
. Science of Advanced Materials 13:11, pages 2082-2089.
Crossref
Crossref
Elena G. Varlamova, Egor A. Turovsky & Ekaterina V. Blinova. (2021) Therapeutic Potential and Main Methods of Obtaining Selenium Nanoparticles. International Journal of Molecular Sciences 22:19, pages 10808.
Crossref
Crossref
Mohamed Fawzi Kabil, Maha Nasr & Ibrahim M. El-Sherbiny. (2021) Conventional and hybrid nanoparticulate systems for the treatment of hepatocellular carcinoma: An updated review. European Journal of Pharmaceutics and Biopharmaceutics 167, pages 9-37.
Crossref
Crossref
Chaoqun Ma, Yichao Duan, Chaohui Wu, Erjuan Meng, Pingping Li, Zhenzhong Zhang, Chunhua Zang & Xueling Ren. (2021) Spatiotemporally co-delivery of triple therapeutic drugs via HA-coating nanosystems for enhanced immunotherapy. Asian Journal of Pharmaceutical Sciences 16:5, pages 653-664.
Crossref
Crossref
Cláudio Ferro, Helena F. Florindo & Hélder A. Santos. (2021) Selenium Nanoparticles for Biomedical Applications: From Development and Characterization to Therapeutics. Advanced Healthcare Materials 10:16.
Crossref
Crossref
Deep S. Bhattacharya, Aishwarya Bapat, Denis Svechkarev & Aaron M. Mohs. (2021) Water-Soluble Blue Fluorescent Nonconjugated Polymer Dots from Hyaluronic Acid and Hydrophobic Amino Acids. ACS Omega 6:28, pages 17890-17901.
Crossref
Crossref
Mohammed Mehadi Hassan Chowdhury, Christiancel Joseph J. Salazar & Md Nurunnabi. (2021) Recent advances in bionanomaterials for liver cancer diagnosis and treatment. Biomaterials Science 9:14, pages 4821-4842.
Crossref
Crossref
Yu Xia, Guoyi Tang, Yi Chen, Changbing Wang, Min Guo, Tiantian Xu, Mingqi Zhao & Yongjian Zhou. (2021) Tumor-targeted delivery of siRNA to silence Sox2 gene expression enhances therapeutic response in hepatocellular carcinoma. Bioactive Materials 6:5, pages 1330-1340.
Crossref
Crossref
Maryam Sharifiaghdam, Elnaz Shaabani, Zeynab Sharifiaghdam, Herlinde De Keersmaecker, Riet De Rycke, Stefaan De Smedt, Reza Faridi-Majidi, Kevin Braeckmans & Juan C. Fraire. (2021) Enhanced siRNA Delivery and Selective Apoptosis Induction in H1299 Cancer Cells by Layer-by-Layer-Assembled Se Nanocomplexes: Toward More Efficient Cancer Therapy. Frontiers in Molecular Biosciences 8.
Crossref
Crossref
Diedie Li, Chengzhi Gao, Meiyan Kuang, Minhao Xu, Ben Wang, Yi Luo, Lesheng Teng & Jing Xie. (2021) Nanoparticles as Drug Delivery Systems of RNAi in Cancer Therapy. Molecules 26:8, pages 2380.
Crossref
Crossref
Saffiya Habib, Mario Ariatti & Moganavelli Singh. (2020) Anti-c-myc RNAi-Based Onconanotherapeutics. Biomedicines 8:12, pages 612.
Crossref
Crossref
Irina A. Shurygina & Michael G. Shurygin. 2020. Nanobiotechnology in Diagnosis, Drug Delivery, and Treatment. Nanobiotechnology in Diagnosis, Drug Delivery, and Treatment
25
45
.
I. A. Shurygina & M. G. Shurygin. (2021) Use of Nanoselenium in Chemotherapy Drug Delivery Systems. Nanotechnologies in Russia 15:11-12, pages 679-685.
Crossref
Crossref
Bo Yang, Anlin Hao & Lin Chen. (2020) Mirror siRNAs loading for dual delivery of doxorubicin and autophagy regulation siRNA for multidrug reversing chemotherapy. Biomedicine & Pharmacotherapy 130, pages 110490.
Crossref
Crossref
Huaiyu Zhang, Shujun Dong, Zhongmin Li, Xiangru Feng, Weiguo Xu, Catrina Mae S. Tulinao, Yang Jiang & Jianxun Ding. (2020) Biointerface engineering nanoplatforms for cancer-targeted drug delivery. Asian Journal of Pharmaceutical Sciences 15:4, pages 397-415.
Crossref
Crossref
Chenyang Xing, Peng Yin, Zhengchun Peng & Han Zhang. (2020) Engineering Mono‐Chalcogen Nanomaterials for Omnipotent Anticancer Applications: Progress and Challenges. Advanced Healthcare Materials 9:14.
Crossref
Crossref
Xiong Xiao, Nan Li, Mingyu Wang, Chunxia Xiong, Dengfeng Xie, Xinyue Chu, Yunxin Li, Yun Huang, Wenhui Ling, Yuemin Li & Xiaoyan Qiu. (2020) Delivery of plasmid DNA encoding Oct 4 with polyethylenimine-modified superparamagnetic iron oxide nanoparticles in HEK-293T cells. Journal of Nanoparticle Research 22:5.
Crossref
Crossref
Na Yin, Xinyi Tan, Hongbing Liu, Fengming He, Ning Ding, Jingxin Gou, Tian Yin, Haibing He, Yu Zhang & Xing Tang. (2020)
A novel indomethacin/methotrexate/MMP-9 siRNA
in situ
hydrogel with dual effects of anti-inflammatory activity and reversal of cartilage disruption for the synergistic treatment of rheumatoid arthritis
. Nanoscale 12:15, pages 8546-8562.
Crossref
Crossref
Rami Alzhrani, Hashem O. Alsaab, Alex Petrovici, Ketki Bhise, Kushal Vanamala, Samaresh Sau, Matthew J. Krinock & Arun K. Iyer. (2020) Improving the therapeutic efficiency of noncoding RNAs in cancers using targeted drug delivery systems. Drug Discovery Today 25:4, pages 718-730.
Crossref
Crossref
Samie Yaseen Sharaf Zeebaree, Aymn Yaseen Sharaf Zeebaree & Osama Ismail Haji Zebari. (2020) Diagnosis of the multiple effect of selenium nanoparticles decorated by Asteriscus graveolens components in inhibiting HepG2 cell proliferation. Sustainable Chemistry and Pharmacy 15, pages 100210.
Crossref
Crossref
Hyun-Jong Cho. (2019) Recent progresses in the development of hyaluronic acid-based nanosystems for tumor-targeted drug delivery and cancer imaging. Journal of Pharmaceutical Investigation 50:2, pages 115-129.
Crossref
Crossref
Yu Xia, Misi Xiao, Mingqi Zhao, Tiantian Xu, Min Guo, Changbing Wang, Yinghua Li, Bing Zhu & Hongsheng Liu. (2020) Doxorubicin-loaded functionalized selenium nanoparticles for enhanced antitumor efficacy in cervical carcinoma therapy. Materials Science and Engineering: C 106, pages 110100.
Crossref
Crossref
Devesh Kapoor, Yashu Chourasiya, Anil Pethe, Rahul Maheshwari & Rakesh K. Tekade. 2020. The Future of Pharmaceutical Product Development and Research. The Future of Pharmaceutical Product Development and Research
341
365
.
Jinyu Li, Hao Pan, Sen Qiao, Yunjian Li, Jie Wang, Wei Liu & Weisan Pan. (2019) The utilization of low molecular weight heparin-poloxamer associated Laponite nanoplatform for safe and efficient tumor therapy. International Journal of Biological Macromolecules 134, pages 63-72.
Crossref
Crossref
Yinghua Li, Tiantian Xu, Zhengfang Lin, Changbing Wang, Yu Xia, Min Guo, Mingqi Zhao, Yi Chen & Bing Zhu. (2019) Inhibition of Enterovirus A71 by Selenium Nanoparticles Interferes with JNK Signaling Pathways. ACS Omega 4:4, pages 6720-6725.
Crossref
Crossref
Shaheen Mahira, Nagavendra Kommineni, Gulam Mohammed Husain & Wahid Khan. (2019) Cabazitaxel and silibinin co-encapsulated cationic liposomes for CD44 targeted delivery: A new insight into nanomedicine based combinational chemotherapy for prostate cancer. Biomedicine & Pharmacotherapy 110, pages 803-817.
Crossref
Crossref
Heng Wee Tan, Hai-Ying Mo, Andy T. Y. Lau & Yan-Ming Xu. (2018) Selenium Species: Current Status and Potentials in Cancer Prevention and Therapy. International Journal of Molecular Sciences 20:1, pages 75.
Crossref
Crossref
Yu Xia, Tiantian Xu, Mingqi Zhao, Liang Hua, Yi Chen, Changbing Wang, Ying Tang & Bing Zhu. (2018) Delivery of Doxorubicin for Human Cervical Carcinoma Targeting Therapy by Folic Acid-Modified Selenium Nanoparticles. International Journal of Molecular Sciences 19:11, pages 3582.
Crossref
Crossref
Yu Xia, Mingqi Zhao, Yi Chen, Liang Hua, Tiantian Xu, Changbing Wang, Yinghua Li & Bing Zhu. (2018) Folate-targeted selenium nanoparticles deliver therapeutic siRNA to improve hepatocellular carcinoma therapy. RSC Advances 8:46, pages 25932-25940.
Crossref
Crossref